Oncogene - Table of Contents alert Volume 32 Issue 8

TABLE OF CONTENTS Volume 32, Issue 8 (February 2013) In this issue Review Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Check out Oncogenesis’s most downloaded article in January MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? Open This review aims to summarize the recent advancement about the roles of miRNAs in CRCSCs that may represent a step forward in understanding the molecular mechanisms and the possible approaches for colorectal cancer therapy.   Review Top Targeting genetic alterations in protein methyltransferases for personalized cancer therapeutics Open R A Copeland, M P Moyer and V M Richon Oncogene 2013 32: 939-946; advance online publication, November 19, 2012; 10.1038/onc.2012.552 Abstract | Full Text Original Articles Top Prox1 suppresses the proliferation of neuroblastoma cells via a dual action in p27-Kip1 and Cdc25A I P Foskolou, D Stellas, I Rozani, M D Lavigne and P K Politis Oncogene 2013 32: 947-960; advance online publication, April 16, 2012; 10.1038/onc.2012.129 Abstract | Full Text Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model N Alikhani, R D Ferguson, R Novosyadlyy, E J Gallagher, E J Scheinman, S Yakar and D LeRoith Oncogene 2013 32: 961-967; advance online publication, April 2, 2012; 10.1038/onc.2012.113 Abstract | Full Text p53 modulates homologous recombination at I-SceI-induced double-strand breaks through cell-cycle regulation T Rieckmann, M Kriegs, L Nitsch, K Hoffer, G Rohaly, S Kocher, C Petersen, E Dikomey, I Dornreiter and J Dahm-Daphi Oncogene 2013 32: 968-975; advance online publication, April 9, 2012; 10.1038/onc.2012.123 Abstract | Full Text Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer J Xu, Y Li, F Wang, X Wang, B Cheng, F Ye, X Xie, C Zhou and W Lu Oncogene 2013 32: 976-987; advance online publication, April 2, 2012; 10.1038/onc.2012.121 Abstract | Full Text Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-κB-dependent manner L Wagner, V Marschall, S Karl, S Cristofanon, K Zobel, K Deshayes, D Vucic, K-M Debatin and S Fulda Oncogene 2013 32: 988-997; advance online publication, April 2, 2012; 10.1038/onc.2012.108 Abstract | Full Text ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis Open F Galeano, C Rossetti, S Tomaselli, L Cifaldi, M Lezzerini, M Pezzullo, R Boldrini, L Massimi, C M Di Rocco, F Locatelli and A Gallo Oncogene 2013 32: 998-1009; advance online publication, April 23, 2012; 10.1038/onc.2012.125 Abstract | Full Text PKCα phosphorylation of RhoGDI2 at Ser31 disrupts interactions with Rac1 and decreases GDI activity E M Griner, M E A Churchill, D L Brautigan and D Theodorescu Oncogene 2013 32: 1010-1017; advance online publication, April 2, 2012; 10.1038/onc.2012.124 Abstract | Full Text Identification of a pivotal endocytosis motif in c-Met and selective modulation of HGF-dependent aggressiveness of cancer using the 16-mer endocytic peptide K-W Cho, J H Park, C-W Park, D Lee, E Lee, D J Kim, K J Kim, S H Yoon, Y Park, E Kim, S Cho, S Jang, B-C Park, S-W Chi, S H Yoo, M H Jang, H N Kim, E Kim, K Jo and Y W Park Oncogene 2013 32: 1018-1029; advance online publication, April 23, 2012; 10.1038/onc.2012.122 Abstract | Full Text Disrupting the PIKE-A/Akt interaction inhibits glioblastoma cell survival, migration, invasion and colony formation Q Qi, K He, X Liu, C Pham, C Meyerkord, H Fu and K Ye Oncogene 2013 32: 1030-1040; advance online publication, March 26, 2012; 10.1038/onc.2012.109 Abstract | Full Text Egr-1 mediates epidermal growth factor-induced downregulation of E-cadherin expression via Slug in human ovarian cancer cells J-C Cheng, H-M Chang and P C K Leung Oncogene 2013 32: 1041-1049; advance online publication, April 16, 2012; 10.1038/onc.2012.127 Abstract | Full Text p14ARF inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway P Ozenne, D Dayde, E Brambilla, B Eymin and S Gazzeri Oncogene 2013 32: 1050-1058; advance online publication, March 26, 2012; 10.1038/onc.2012.107 Abstract | Full Text MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells J H Schulte, S Lindner, A Bohrer, J Maurer, K De Preter, S Lefever, L Heukamp, S Schulte, J Molenaar, R Versteeg, T Thor, A Künkele, J Vandesompele, F Speleman, H Schorle, A Eggert and A Schramm Oncogene 2013 32: 1059-1065; advance online publication, April 9, 2012; 10.1038/onc.2012.106 Abstract | Full Text Short Communication Top Rapid generation of human B-cell lymphomas via combined expression of Myc and Bcl2 and their use as a preclinical model for biological therapies I Leskov, C P Pallasch, A Drake, B P Iliopoulou, A Souza, C-H Shen, C D Schweighofer, L Abruzzo, L P Frenzel, C M Wendtner, M T Hemann and J Chen Oncogene 2013 32: 1066-1072; advance online publication, April 9, 2012; 10.1038/onc.2012.117 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.